LRRC50 Antikörper (N-Term)
Kurzübersicht für LRRC50 Antikörper (N-Term) (ABIN631930)
Target
Alle LRRC50 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- LRRC50 antibody was raised against the N terminal of LRRC50
-
Aufreinigung
- Affinity purified
-
Immunogen
- LRRC50 antibody was raised using the N terminal of LRRC50 corresponding to a region with amino acids LNDTLYLHFKGFDRIENLEEYTGLRCLWLQSNGIQKIENLEAQTELRCLF
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
LRRC50 Blocking Peptide, (ABIN5614577), is also available for use as a blocking control in assays to test for specificity of this LRRC50 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LRRC50 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LRRC50 (Leucine Rich Repeat Containing 50 (LRRC50))
-
Andere Bezeichnung
- LRRC50
-
Hintergrund
- LRRC50 contains 6 LRR (leucine-rich) repeats. It is proposed that LRRC50 to be a novel candidate gene for human cystic kidney disease, involved in regulation of microtubule-based cilia and actin-based brush border microvilli.
-
Molekulargewicht
- 80 kDa (MW of target protein)
Target
-